医脉通心内科频道|施仲伟教授:短期双抗后长期阿司匹林单药治疗成为PCI术后高出血风险患者治疗新选择|TCT2020( 三 )


医脉通心内科频道|施仲伟教授:短期双抗后长期阿司匹林单药治疗成为PCI术后高出血风险患者治疗新选择|TCT2020
本文插图
施仲伟教授
【医脉通心内科频道|施仲伟教授:短期双抗后长期阿司匹林单药治疗成为PCI术后高出血风险患者治疗新选择|TCT2020】医学博士 , 上海交通大学医学院附属瑞金医院心脏科教授 , 主任医师 。 兼任中国老年学学会心脑血管病专业委员会常务委员 , 上海市超声质量控制中心专家委员会委员 , 国家自然科学基金委员会医学科学部评审专家 。 《中华心脏与心律电子杂志》、《中华医学杂志》、《中华内科杂志》等10多本杂志的副主编、编委或特约审稿专家 , 发表论文500多篇 , 主编或参编《内科手册》、《心血管疾病诊治策略》、《中国国家处方集》、《中华医学百科全书》、《临床超声影像学》等专著30多本 。 美国心脏协会会员 , 欧洲心脏学会会员 , 1996年获世界心血管超声学会和中华医学会联合授予“超声贡献奖” , 2013年获美国心脏学会授予“国际交流奖” 。
参考文献:[1] Mehta SR, Yusuf S, Peters RJ, etal. Effects of pretreatment withclopidogrel and aspirin followed by long-term therapy in patients undergoingpercutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533.[2] Mauri L, Kereiakes DJ, Yeh RW, etal. Twelve or 30 Months of DualAntiplatelet Therapy after Drug-Eluting Stents. N Engl J Med, 2014, 371(23):2155-2166.[3] Schulz-Schupke S, Byrne RA, tenBerg JM, et al. ISAR-SAFE: a randomized,double-blind, placebo- controlled trial of 6 versus 12 months of clopidogreltherapy after drug-eluting stenting. EurHeart J, 2015, 36(20):1252-1263.[4] Varenne O, Cook S, Sideris G, etal. Drug-eluting stents in elderlypatients with coronary artery disease (SENIOR): a randomised single-blind trial. Lancet, 2018, 391(10115):41-50.[5] Neumann FJ, Sousa-Uva M, Ahlsson A,et al. 2018 ESC/EACTS Guidelines onmyocardial revascularization. Eur Heart J, 2019, 40(2): 87-165.[6] Collet JP, Thiele H, Barbato E, etal. 2020 ESC Guidelines forthe management of acute coronary syndromes in patients presenting without persistentST-segment elevation. Eur Heart J. 2020Aug 29, ehaa575.[7] Capodanno D, Morice MC, AngiolilloDJ, et al.Trial Design Principles for Patients atHigh Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel. J Am Coll Cardiol, 2020, 76(12):1468-1483.[8] Roxana Mehran.TCT2020.The XIENCE Short DAPT Program: XIENCE 90/28 - Evaluating theSafety of 3-month and 1-month DAPT in HBR Patients. https://www.acc.org/-/media/Clinical/PDF-Files/Approved-PDFs/2020/10/12/TCT20/Oct15-Thur/1245pmET-XIENCE-tct-2020.pdf[9]Valgimigli M, Cao D, Makkar RR, et al., Design and Rationale of the XIENCEShort DAPT Clinical Program: an Assessment of the Safety of 3-month or 1-monthDAPT in Patients at High Bleeding Risk Undergoing PCI with anEverolimus-Eluting Stent, American Heart Journal (2020),https://doi.org/10.1016/j.ahj.2020.09.019[10] Naidu SS, Krucoff MW, Rutledge DR,et al. Contemporary Incidence andPredictors of Stent Thrombosis and Other Major Adverse Cardiac Events in theYear After XIENCE V Implantation: Results From the 8,061-Patient XIENCE VUnited States Study. JACC CardiovascInterv, 2012, 5(6):626-635.


推荐阅读